ACADIA Pharmaceuticals Inc. (ACAD) Stock Guide

June 12, 2020
71

Before we start: if you're looking for ACAD stock price, you can quickly find it out by visiting Finny and typing "ACAD quote". If you're looking for a quick scoop on ACAD stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "ACAD". You'll get all this info in one place. Or you can just type "ACAD news" to get the latest stock news.

Looking to buy or sell ACADIA Pharmaceuticals Inc. (ACAD)? Interested in getting the full scoop on ACAD, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this ACAD stock guide, we'll address key questions about ACAD, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are ACAD earnings?
2. When is ACAD earnings date?
3. What is ACAD stock forecast (i.e., prediction)?
4. ACAD buy or sell? What is ACAD Finny Score?
5. What are the reasons to buy ACAD? Why should I buy ACAD stock?
6. What are the reasons to sell ACAD? Why should I sell ACAD stock?
7. What are ACAD key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are ACAD earnings?

ACAD trailing 12-month earnings per share (EPS) is -$1.59.

2. When is ACAD earnings date?

ACAD earnings date is July 29, 2020.

Analyst Predictions

3. What is ACAD stock forecast (i.e., prediction)?

Based on ACAD analyst price targets, ACAD stock forecast is $57.82 (for a year from now). That means the average analyst price target for ACAD stock is $57.82. The prediction is based on 10 analyst estimates.

The low price target for ACAD is $41.00, while the high price target is $72.00.

ACAD analyst rating is Buy.

Analysis

4. ACAD buy or sell? What is ACAD Finny Score?

Our quantitative analysis shows 5 reasons to buy and 2 reasons to sell ACAD, resulting in Finny Score of 71.

5. What are the reasons to buy ACAD? Why should I buy ACAD stock?

Here are the reasons to buy ACAD stock:

  • ACAD quarterly revenue growth was 43.10%, higher than the industry and sector average revenue growth (0.52% and 1.16%, respectively). See ACAD revenue growth chart.
  • ACAD profitability is improving. The YoY profit margin change was 122.15 percentage points. See ACAD profitability chart.
  • ACAD average analyst rating is Buy. See ACAD analyst rating chart.
  • ACAD average analyst price target ($57.82) is above its current price ($45.19). See ACAD price target chart.
  • ACAD cash to debt ratio is 106.96, higher than the average industry (0.16) and sector (0.16) cash to debt ratio. See ACAD cash to debt chart.

6. What are the reasons to sell ACAD? Why should I sell ACAD stock?

Let's look at the reasons to sell ACAD stock (i.e., the bear case):

  • ACAD short share of float is 13.05%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See ACAD short share of float chart.
  • ACAD short interest (days to cover the shorts) ratio is 8.88. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ACAD short interest ratio chart.

Key Stats

7. What are ACAD key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for ACAD:

Metrics ACAD
Price $51.61
Average Price Target / Upside $57.82 / 12.03%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 430
Market Cap $7.38B
Forward P/E Ratio -115.51
Price/Book Ratio 20.16
Revenue (TTM) $366.18M
YoY Quarterly Revenue Growth 43.10%
Profit Margin -64.99%

If you liked this analysis, check out Stock Guides for other stocks.

Follow Us